Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study.

Scientific reports·2022
Same author

Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study).

International journal of clinical oncology·2022
Same author

Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.

Journal of nephrology·2022
Same author

Intended preoperative trans-arterial embolization for large hepatocellular carcinoma: a retrospective cohort study.

World journal of surgical oncology·2022
Same author

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma.

Cancer medicine·2022
Same author

Correction to: Association between expanded criteria for living kidney donors and renal biopsy findings.

Journal of nephrology·2022

Related Experiment Video

Updated: Jun 25, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

1.8K

Machine learning-based diagnostic prediction of IgA nephropathy: model development and validation study.

Ryunosuke Noda1, Daisuke Ichikawa2, Yugo Shibagaki2

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, Kanagawa, 216-8511, Japan. nodaryu00@gmail.com.

Scientific Reports
|May 30, 2024
PubMed
Summary

Early detection of IgA nephropathy is crucial. Machine learning models accurately predict IgA nephropathy non-invasively using routine tests, avoiding kidney biopsy.

Keywords:
Artificial intelligenceGlomerulonephritisIgA nephropathyKidney biopsyMachine learning

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.7K

Related Experiment Videos

Last Updated: Jun 25, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

1.8K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.7K

Area of Science:

  • Nephrology
  • Medical Informatics
  • Machine Learning

Background:

  • Immunoglobulin A (IgA) nephropathy is a leading cause of kidney failure.
  • Current diagnosis relies on invasive kidney biopsy, limiting early detection.
  • Developing non-invasive methods is essential for timely IgA nephropathy management.

Purpose of the Study:

  • To develop and validate non-invasive prediction models for IgA nephropathy.
  • To utilize machine learning algorithms for enhanced diagnostic accuracy.
  • To identify key clinical predictors for IgA nephropathy.

Main Methods:

  • Retrospective analysis of demographic, blood, and urine test data from 1268 participants.
  • Development and temporal validation of five machine learning models (XGBoost, LightGBM, Random Forest, ANN, 1D-CNN) and logistic regression.
  • Performance evaluation using Area Under the Receiver Operating Characteristic Curve (AUROC) and variable importance analysis (SHAP).

Main Results:

  • Machine learning models achieved high predictive performance, with XGBoost showing the highest AUROC of 0.894 in the validation cohort.
  • LightGBM achieved an AUROC of 0.913 in the derivation cohort, outperforming several other models.
  • Key predictors identified include age, serum albumin, IgA/C3 ratio, and urine red blood cells.

Conclusions:

  • Machine learning offers a promising non-invasive approach for predicting IgA nephropathy.
  • These models can aid in early detection and potentially reduce the need for kidney biopsies.
  • The identified predictors align with established clinical understanding of IgA nephropathy progression.